Medical cannabis R&D firm Kanabo Group (LON: KNB) said on Tuesday that Materia’s subsidiary, Materia Malta Operating, has received a licence to produce cannabis for medicinal and research purposes from the Malta Medicines Authority.
In July this year, Kanabo announced a non-binding term sheet with Materia to acquire its European businesses, including Materia Malta.
Kanabo’s share price jumped to a high of 19.4p on the news, up over 7% from Monday’s 2% rise and close at 18p.
Ready to put what you’ve learned into practice?
Try IG’s platform with £10,000 in virtual funds and practise trading
without putting your own money at risk.
Try IG with a demo account →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Learn the markets with IG Academy
Build your knowledge with IG Academy educational content, then use a
demo account to practise what you’ve learned on the IG platform.
Explore IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
See how trading works before risking real money
IG’s demo gives you access to thousands of markets and £10,000 in
virtual funds, so you can explore the platform and test your ideas first.
Open an IG demo →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Turn trading theory into practical experience
Learn with IG Academy, explore charts and market tools, and practise
strategies in a simulated trading environment before going live.
Start practising with IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Ready to take your learning further?
IG combines market education, analysis and an established trading platform,
giving you the tools to keep learning as you develop your trading skills.
Discover IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
The receipt of the licence is the final requirement for Materia Malta to begin commercial production and export of medical cannabis for commercial purposes. Materia Malta is already EU GMP certified, and has an annual capacity of 6,000kg, representing a potential sale value of approximately €36M.
Materia Malta is now in the process of importing its first batch of raw material for commercial production. Kanabo said Materia Malta will begin fulfilling its supply commitments across Europe imminently, starting with the initial target markets of Germany, Malta and the UK. The first product is already registered on the narcotics licence of Materia Deutschland GmbH ahead of its import into Germany.
“Materia’s progress is remarkable. Subject to completion of the merger, the facility in Malta will enable Kanabo’s enlarged group to broaden its distribution across Europe and solidify our plan for a complete supply and distribution line,” said Kanabo CEO Avihu Tamir.
Should You Invest in Kanabo Shares?
One of the most frequently asked questions we receive is, “what stocks are best to buy right now?” It’s a wide-ranging question, but one that we have answered… Our AskTraders stock analysts regularly review the market and compile a list of which companies you should be adding to your portfolio, including short and longer-term positions. Here are the best stocks to buy right now